International Journal of Clinical Oncology and Cancer Research

Volume 10, Issue 2, June 2025

  • Research Article

    Comparative Prospective Study Assessing Early Clinical Outcomes with or Without Use of Contrast Enhancement in CT Based Image Guided HDR Brachytherapy

    Shreya Dwivedi*, Aswin Chandran Veluthattil, Madhulika Vijayakumar, Nithiyaanandan Natarajan, Anjali Thiruthiyil, Dinesh Babu, Shankar Sekar

    Issue: Volume 10, Issue 2, June 2025
    Pages: 36-50
    Received: 3 March 2025
    Accepted: 12 March 2025
    Published: 26 March 2025
    Downloads:
    Views:
    Abstract: Background: Brachytherapy has been part of the standard of care in the treatment of cervical cancer. Brachytherapy has evolved from two to three-dimensional treatment for better volume delineation for target and OAR thus leading to better LC and reduced toxicities. Presently, MR Brachytherapy is the gold standard. However, its use is limited by its... Show More
  • Research Article

    Evaluation of Response and Toxicity of Pemetrexed-Carboplatin Versus Paclitaxel-Carboplatin as First-Line Treatment in Metastatic NSCLC

    Uday Kumar Sarkar*, Sarwar Alam, Syed Md Asadul Hoque, Newton Kumar Sarker, Tasnim Mahmud, Safayet Hossain

    Issue: Volume 10, Issue 2, June 2025
    Pages: 51-58
    Received: 2 March 2025
    Accepted: 12 March 2025
    Published: 28 March 2025
    Downloads:
    Views:
    Abstract: Non-small cell lung cancer (NSCLC) accounts for 80-85% of all lung cancer approximately. The paclitaxel-carboplatin combination is the established standard regimen of choice in metastatic NSCLC. Pemetrexed, a folate antimetabolite is also effective against non-small cell lung cancer. To compare the response and toxicity of the Pemetrexed-Carboplati... Show More
  • Research Article

    Assessing the Impact of Chemoradiotherapy and Surgery on 2-Year Survival of Triple Negative Breast Cancer Patients- A Prospective Follow-Up Study

    Shamsun Nahar*, Afsana Sharmin Anika, Rumana Afroz Majumder, Khursheda Akhter, Faruk Ahmed, Nasrin Akhter, Fariha Chowdhury, Saimum Islam

    Issue: Volume 10, Issue 2, June 2025
    Pages: 59-66
    Received: 17 March 2025
    Accepted: 31 March 2025
    Published: 22 April 2025
    DOI: 10.11648/j.ijcocr.20251002.13
    Downloads:
    Views:
    Abstract: Triple-negative breast cancer is a rising concern recently as incidence and deaths have doubled within two years. Despite various proven risk factors and effective therapies, improvements in survival rates have not been up to the mark. This study evaluated 110 patients with histologically proven stage I-III TNBC with invasive ductal carcinoma treat... Show More